Lead sponsor
Annovis Bio Inc.
5 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
5
Trials led
1
Ongoing
1,209
Total enrollment
138
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Phase 1/2
2
Phase 2/3
1
Phase 3
1
Trials by status
Active, not recruiting
1
Completed
3
Terminated
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early ADAlzheimer's diseasePh 3Active, not recruiting760
A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate ADAlzheimer's diseasePh 2/3Completed351
Posiphen® Dose-Finding, Biomarker Study in Early Alzheimer's and Parkinson's PatientsMMSE 18-28Ph 1/2Completed75